Cargando…
mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment
The life span of dendritic cells (DCs) can become short following induced activation, which is associated with metabolic transition due to the regulation of mechanistic target of rapamycin (mTOR). The purpose of this study was to investigate the potential of inhibiting mTOR to modulate DC functions...
Autores principales: | Chen, Yu-Li, Lin, Han-Wei, Sun, Nai-Yun, Yie, Jr-Chi, Hung, Hsueh-Chih, Chen, Chi-An, Sun, Wei-Zen, Cheng, Wen-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562783/ https://www.ncbi.nlm.nih.gov/pubmed/31052575 http://dx.doi.org/10.3390/cancers11050617 |
Ejemplares similares
-
Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018) -
Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
por: Lin, Hugo You-Hsien, et al.
Publicado: (2014) -
Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin
por: Saito, Keita, et al.
Publicado: (2012) -
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019) -
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors
por: Hassan, Burhan, et al.
Publicado: (2014)